MONTREAL, QUEBEC -- (MARKET WIRE) -- August 25, 2006 -- Mistral Pharma Inc. (TSX VENTURE: MIP) (the “Corporation”, “Mistral”) announces today its financial results and review of operating highlights for the three-month period ended June 30, 2006. “The highlight of the quarter is certainly the completion of the $5 million private placement initiated in March 2006 as the remaining $4.5 million was closed in May 2006. This financing will provide Mistral with sufficient financial resources to accelerate the development of our branded product line” said Mr. Bertrand Bolduc, the Corporation’s President & CEO.
